ECIA (Encision) YoY EBITDA Growth: -45.45% (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ECIA Encision Inc ECIA
35 GF Score
Price $0.19
GF Value $0.34
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Encision YoY EBITDA Growth?

Encision ECIA 35 YoY EBITDA Growth is -45.45% as of Sep. 2025. GuruFocus rates ECIA with a GF Score™ of 35/100 and a GF Value™ of $0.34 (Possible Value Trap). The stock has 3 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Encision's YoY EBITDA Growth for the quarter that ended in Sep. 2025 was -45.45%.

Encision's EBITDA per Share for the three months ended in Sep. 2025 was $-0.02.

Encision YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for Encision's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encision YoY EBITDA Growth Chart

Encision Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,600.00 -92.31 -480.00 -142.11 82.61

Encision Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -466.67 100.00 96.15 -100.00 -45.45
ECIA
35GF Score
Encision Inc ECIA
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Encision YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Encision's YoY EBITDA Growth for the fiscal year that ended in Mar. 2025 is calculated as:

YoY EBITDA Growth (A: Mar. 2025 )
=(EBITDA per Share (A: Mar. 2025 )-EBITDA per Share (A: Mar. 2024 ))/ | EBITDA per Share (A: Mar. 2024 ) |
=(-0.008--0.046)/ | -0.046 |
=82.61 %

Encision's YoY EBITDA Growth for the quarter that ended in Sep. 2025 is calculated as:

YoY EBITDA Growth (Q: Sep. 2025 )
=(EBITDA per Share (Q: Sep. 2025 )-EBITDA per Share (Q: Sep. 2024 )) / | EBITDA per Share (Q: Sep. 2024 )) |
=(-0.016--0.011)/ | -0.011 |
=-45.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -45.45% mean?
Encision (ECIA) has a YoY EBITDA Growth of -45.45% as of Sep. 2025. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Encision and its competitors.
Is Encision's YoY EBITDA Growth too high?
Encision's current YoY EBITDA Growth is -45.45%. Overall, Encision has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Encision's YoY EBITDA Growth compare to GCTK and YBGJ?
Encision's YoY EBITDA Growth of -45.45% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Medical Devices & Instruments company?
A good YoY EBITDA Growth depends on the Medical Devices & Instruments industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for Encision and its competitors. Encision's current YoY EBITDA Growth is -45.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encision stock overvalued right now?
Based on GuruFocus' analysis, Encision (ECIA) is currently considered Possible Value Trap. The stock's GF Value™ is $0.34, compared to a current price of $0.19 — trading 44.1% below its estimated fair value. The current YoY EBITDA Growth is -45.45%. Encision's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For Encision (ECIA), the current YoY EBITDA Growth is -45.45% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Encision (ECIA) Overvalued in 2026?

Based on GuruFocus' analysis, Encision stock appears to be undervalued. The current stock price of $0.19 is trading 44.1% below its estimated GF Value™ of $0.34. GuruFocus considers Encision to be Possible Value Trap.

Key valuation signals for ECIA:

  • YoY EBITDA Growth: -45.45%
  • GF Value™: $0.34 vs. price of $0.19 (44.1% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the ECIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Encision Business Description

Address 6797 Winchester Circle, Boulder, CO, USA, 80301
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Maximum revenue is generated from the product segment.
35GF Score

Get the complete analysis for ECIA

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$0.34
GF Value